Is this intravenous infusion of Vitamin C truly the miracle solution that it is being deemed or is it just another wellness fad that needs more caution than you think? Experts reveal.

Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$15 Billion by 2026, growing at ...

A multi-day intravenous infusion of the local anesthetic lidocaine appears to offer some pain relief to patients battling otherwise untreatable daily migraines. That's the takeaway from a new ...

IV infusions for ulcerative colitis have been helping many people improve their quality of life. ... standard of care is typically going to be three days of intravenous steroids,” Cross explains.

Repeated intravenous (IV) administration of iron reduced the risk of hospitalization for heart failure and cardiovascular death in people with heart failure and iron deficiency, according to a ...

As part of the updated EUA, REGEN-COV should be administered by intravenous (IV) infusion; subcutaneous (SC) injections are an alternative when IV infusion is not feasible and would lead to a ...

When you imagine a patient in a hospital bed you will probably picture an intravenous (IV) drip as part of the scene. Between 80% and 90% of hospital inpatients will receive an infusion of one or more ...

Regulating IV infusion with innovative blind cave fish-inspired sensor. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2016 / 01 / 160121133114.htm ...

Hospitals must start using smart intravenous (IV) infusion technology to its full potential if they are to prevent dangerous drug errors, University of Manchester researchers have found. Smart ...

In the current study, the researchers aimed to examine the tolerability, safety, pharmacokinetics (PK), and pharmacodynamics (PD) of single 30- or 60-mg/kg IV doses of nipocalimab in healthy ...

The Food and Drug Administration (FDA) has approved an intravenous (IV) formulation of Cosentyx ® (secukinumab) for the treatment of adults with psoriatic arthritis (PsA), ankylosing spondylitis ...